Related Experiment Video

Updated: May 5, 2026

Capsular Serotyping of Streptococcus pneumoniae Using the Quellung Reaction
04:25

Capsular Serotyping of Streptococcus pneumoniae Using the Quellung Reaction

Published on: February 24, 2014

45.7K

Meningococcal Surveillance Australia: Reporting period 1 July to 30 September 2023

Monica M Lahra1,2, Tiffany R Hogan1

  • 1World Health Organization Collaborating Centre for STI and AMR, Sydney; Neisseria Reference Laboratory, New South Wales Health Pathology, Microbiology, The Prince of Wales Hospital, Randwick, NSW 2031, Australia.

Communicable Diseases Intelligence (2018)
|June 27, 2024
PubMed

Insights

The Australian Meningococcal Surveillance Programme (AMSP) tracks invasive meningococcal disease (IMD) cases. Laboratory data provides quarterly updates on IMD case numbers by region and serogroup.

Area of Science:

  • Public Health Microbiology
  • Epidemiology
  • Infectious Disease Surveillance

Background:

  • Invasive meningococcal disease (IMD) remains a significant public health concern globally.
  • Effective surveillance is crucial for understanding disease burden and guiding control strategies.
  • The Australian Meningococcal Surveillance Programme (AMSP) plays a vital role in monitoring IMD across Australia.

Purpose of the Study:

  • To report on the number of laboratory-confirmed invasive meningococcal disease (IMD) cases in Australia.
  • To provide timely data on IMD incidence by jurisdiction and serogroup.
  • To serve as a basis for the AMSP's comprehensive annual reports.

Main Methods:

  • Laboratory confirmation of IMD cases using culture and molecular-based techniques.
  • Data collection and reporting by AMSP reference laboratories.
  • Categorization of cases by geographical jurisdiction and Neisseria meningitidis serogroup.

Main Results:

  • Quarterly reports detail the number of confirmed IMD cases.
  • Data is stratified by Australian state and territory.
  • Serogroup information is provided where available.

Conclusions:

  • Quarterly AMSP reports offer essential, up-to-date surveillance data on IMD.
  • This data supports ongoing public health interventions and research.
  • Annual reports provide a more in-depth analysis of IMD trends.

More Related Videos

Capsular Serotyping of Streptococcus pneumoniae by Latex Agglutination09:11

Capsular Serotyping of Streptococcus pneumoniae by Latex Agglutination

Published on: September 25, 2014

21.9K
Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery10:03

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery

Published on: November 5, 2019

7.3K

Related Concept Videos

Pharmacovigilance01:19

Pharmacovigilance

Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
2.0K
Principles of Disease Surveillance01:26

Principles of Disease Surveillance

Disease surveillance is the systematic collection, analysis, and interpretation of health data essential to the planning, implementation, and evaluation of public health practice. This process integrates data dissemination to entities responsible for preventing and controlling disease, injury, and disability. Surveillance systems provide crucial information for action, helping public health authorities make informed decisions to manage and prevent outbreaks, ensure public safety, optimize...
853
Infectious Diseases and Their Occurrence01:28

Infectious Diseases and Their Occurrence

Infectious diseases appear in populations through various transmission patterns, influenced by pathogen characteristics, population immunity, environmental conditions, and social behavior. Understanding these patterns is essential for effective public health surveillance and intervention. These categories—sporadic, outbreak, epidemic, pandemic, and endemic—help frame the nature and scope of disease events.Sporadic diseases occur irregularly and infrequently, without a predictable...
94
Viral Meningitis01:18

Viral Meningitis

Viral meningitis is the most common form of meningitis and is often referred to as aseptic meningitis to indicate the absence of bacterial involvement. It is generally milder than bacterial meningitis, with symptoms including fever, headache, stiff neck, drowsiness, nausea, photophobia, and vomiting. Rarely, more severe manifestations or death may occur. Common causative agents include enteroviruses, particularly coxsackie A and B viruses and echoviruses, all members of the Enterovirus genus...
199
Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
15
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
24